Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 151.16 M141.07 M132.29 M138.33 M138.43 M 550.12 M Research & development 53.22 M59.24 M56.27 M54.95 M55.76 M 226.21 M Operating income -17.71 M-7.45 M7.14 M8.86 M8.76 M 17.31 M Non-Operating Income, Total 5.4 M4.11 M2.89 M2.26 M2.74 M 11.99 M Interest expense, net of interest capitalized 7.01 M7.14 M7.21 M7.06 M6.41 M 27.82 M Non-Operating Income, excl. Interest Expenses -2.08 M-3.06 M-3.62 M-3.66 M-3.37 M -13.71 M Unusual income/expense 474 K25 K-703 K-1.13 M-304 K -2.12 M Pretax income -19.32 M-10.48 M2.81 M-22.93 M5.09 M -25.52 M Equity in earnings ————— — Taxes 3.61 M4.22 M550 K4.8 M3.67 M 13.24 M Non-controlling/minority interest ————— — After tax other income/expense -979 K-168 K-1.29 M-1.06 M-1.35 M -3.88 M Net income before discontinued operations -22.93 M-14.71 M2.26 M-737 K1.41 M -11.77 M Discontinued operations ————— — Net income -22.93 M-14.71 M2.26 M-737 K1.41 M -11.77 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -22.93 M-14.71 M2.26 M-737 K1.41 M -11.77 M Basic earnings per share (Basic EPS) -0.19-0.120.02-0.010.01 -0.1 Diluted earnings per share (Diluted EPS) -0.19-0.120.02-0.010.01 -0.1 Average basic shares outstanding 120.08 M120.98 M120.48 M120.12 M115.9 M — Diluted shares outstanding 120.08 M120.98 M121.95 M120.12 M117.69 M — EBITDA -7.86 M3.38 M18.27 M18.99 M18.99 M 59.63 M EBIT -17.71 M-7.45 M7.14 M8.86 M8.76 M 17.31 M Cost of revenue 52.46 M54.43 M56.75 M55.29 M56.67 M 223.15 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 9.85 M10.83 M11.14 M10.14 M10.23 M 42.33 M